Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis
Annals of Nuclear Medicine · 2024
DOI: 10.1007/s12149-024-01928-2 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Nuclear Medicine, 2024. Verfasst von Naoto Wakabayashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan. Hauptthemen laut MEDLINE: 3-Iodobenzylguanidine, Pheochromocytoma, Paraganglioma, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan.
- Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan.
- Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Kita15, Nishi7, Kita-Ku, Sapporo, Hokkaido, 060-8638, Japan.
- Department of Nuclear Medicine, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan. shirow@med.hokudai.ac.jp.
- Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Kita15, Nishi7, Kita-Ku, Sapporo, Hokkaido, 060-8638, Japan. shirow@med.hokudai.ac.jp.
- Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Kita15, Nishi7, Kita-Ku, Sapporo, Hokkaido, 060-8638, Japan.
Zitieren
APA
Wakabayashi, N., Watanabe, S., Abe, T., Takenaka, J., Hirata, K., Kimura, R., Sakamoto, K., Shinohara, N., & Kudo, K. (2024). Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-024-01928-2
Vancouver
Wakabayashi N, Watanabe S, Abe T, Takenaka J, Hirata K, Kimura R, et al. Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis. Annals of Nuclear Medicine. 2024. doi:10.1007/s12149-024-01928-2
BibTeX
@article{Wakabayashi2024,
author = {Wakabayashi, Naoto and Watanabe, Shiro and Abe, Takashige and Takenaka, Junki and Hirata, Kenji and Kimura, Rina and Sakamoto, Keita and Shinohara, Nobuo and Kudo, Kohsuke},
title = {Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis},
journal = {Annals of Nuclear Medicine},
year = {2024},
doi = {10.1007/s12149-024-01928-2}
}
EUVIMED